Nicholas Lorusso's Stock Coverage
| IOVAIovance Biotherapeutics | Sep 29, 2026 | BUY | Reiterated | $16.00 | 2Ratings | -20.45% | ||
| KROSKeros Therapeutics | Aug 21, 2026 | HOLD | Assigned | ― | 4Ratings | ― | ― | |
| IMTXImmatics | Aug 18, 2026 | BUY | Reiterated | ― | 5Ratings | -29.88% | ||
| ARVNArvinas Holding Company | Aug 04, 2026 | HOLD | Reiterated | ― | 1Ratings | ― | ― | |
| KNSAKiniksa Pharmaceuticals | Jul 28, 2026 | BUY | Assigned | $95.00 | 7Ratings | +90.95% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Nicholas Lorusso activity FAQ
What is the performance of Nicholas Lorusso's recommendations?
The percentage of profitable recommendations made by Nicholas Lorusso is 58.33%, and the average return per transaction is 32.10%.
What stocks does Nicholas Lorusso cover?
What was Nicholas Lorusso's most profitable rating?
Nicholas Lorusso’s most profitable rating was a buy on Kiniksa Pharmaceuticals stock on Oct 28, 2025. The return on the trade was 141.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here